This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bozkurt, O. Articles by Klungel, O. H PubMed PubMed Citation Articles by Bozkurt, O. Articles by Klungel, O. H Social Bookmarking                         What's this?

Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes

Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands

Anthonius de Boer

Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands

Diederik E Grobbee

Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands

Abraham A Kroon

Department of Internal Medicine, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands

Paul Schiffers

Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands

Peter de Leeuw

Department of Internal Medicine, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands

Olaf H Klungel

Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands, o.h.klungel{at}uu.nl

Introduction. We assessed the influence of genetic polymorphisms in the renin-angiotensin system on the risk of diabetes associated with the use of angiotensin II receptor blockers and angiotensin-converting enzyme (ACE) inhibitors.

Materials and methods. We performed a matched case-control study among antihypertensive drug users. Pharmacy records and questionnaires were used to ascertain incident diabetes (cases), antihypertensive drug use, and risk factors. Controls did not (yet) have diabetes.We genotyped ACE (G4656C, which is in complete linkage disequilibrium with the ACE insertion/deletion polymorphism), angiotensinogen (M235T), and angiotensin II type 1 receptor (A1166C).

Results. Among 495 cases of incident diabetes and 2,624 controls, homozygous 1166C carriers of angiotensin II type 1 receptor who used angiotensin II receptor blockers had an increased risk of diabetes compared to 1166A carriers (interaction odds ratio 5.3 [95% confidence interval: 1.8-16.1]). Homozygous ACE GG subjects who used ACE inhibitors 1 defined daily dose/day had a higher risk of diabetes compared to subjects with the ACE C allele (interaction odds ratio 2.3 [95% confidence interval: 1.2-4.5]).

Conclusions. Angiotensin II receptor blockers increase the occurrence of diabetes in homozygous 1166C carriers of angiotensin II type 1 receptor, but not in 1166A carriers. ACE inhibitors at doses 1 defined daily dose/day increase the risk of diabetes among homozygous ACE GG carriers, but not in 4656C carriers.

Key Words: angiotensin-converting enzyme inhibitors • angiotensin II receptor blockers • diabetes mellitus • hypertension • pharmacogenetics

References

• Messerli FH, Grossman E., Goldbourt U. Antihypertensive therapy in diabetic hypertensive patients. Am J Hypertens 2001;14:12S-16S.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Grossman E., Messerli FH, Goldbourt U. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med 2000; 160:2447-52.[Abstract/Free Full Text]
• Elliott WJ, Meyer PM Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007;369:201-07.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lam SK, Owen A. Incident diabetes in clinical trials of antihypertensive drugs. Lancet 2007;369:1513-4; author reply 1514-5.[Web of Science][Medline] [Order article via Infotrieve]
• Jandeleit-Dahm KA, Tikellis C., Reid CM et al. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23:463-73.[Web of Science][Medline] [Order article via Infotrieve]
• Spiering W., Kroon AA, Fuss-Lejeune MM et al. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000;36:411-16.[Abstract/Free Full Text]
• Spiering W., Kroon AA, Fuss-Lejeune MJ et al. Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade. J Hypertens 2005; 23:753-8.[Web of Science][Medline] [Order article via Infotrieve]
• Hilgers KF, Langenfeld MR, Schlaich M. et al. 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation 1999;100:1394-9.[Abstract/Free Full Text]
• Tiret L., Rigat B., Visvikis S. et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.[Web of Science][Medline] [Order article via Infotrieve]
• Rigat B., Hubert C., Alhenc-Gelas F. et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.[Web of Science][Medline] [Order article via Infotrieve]
• Huang XH, Rantalaiho V., Wirta O. et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998;102:372-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bozkurt O., Verschuren WM, van Wieren-de Wijer BM et al. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J Hum Hypertens 2008;22:774-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• van Wieren-de Wijer DB, Maitland-van der Zee AH, de Boer A. et al. Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci 2009;31:158-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus. Geneva, 1999. 15. World Health Organization. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines, 1999.
• Knaapen AM, Ketelslegers HB, Gottschalk RW et al. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin Chem 2004;50:1664-8.[Free Full Text]
• Veldman BA, Spiering W., Doevendans PA et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Villard E., Tiret L., Visvikis S. et al. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996;58:1268-78.[Web of Science][Medline] [Order article via Infotrieve]
• Khoury MJ, Flanders WD Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144:207-13.[Abstract/Free Full Text]
• Yu HM, Lin SG, Liu GZ et al. Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors. Clin Pharmacol Ther 2006;79:581-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yvan-Charvet L., Even P., Bloch-Faure M. et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005;54:991-9.[Abstract/Free Full Text]
• Jandeleit-Dahm KAM, Tikellis C., Reid CM et al. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23:463-73.[Web of Science][Medline] [Order article via Infotrieve]
• Gorden P., Sherman BM, Simopoulos AP Glucose intolerance with hypokalemia: an increased proportion of circulating proinsulin-like component. J Clin Endocrinol Metab 1972;34:235-40.[Abstract/Free Full Text]
• Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 1980;29:498-502.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rapoport MI, Hurd HF Thiazide-induced glucose intolerance treated with potassium. Arch Intern Med 1964;113:405-08.[Abstract/Free Full Text]
• Duncan JA, Scholey JW, Miller JA Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001;1:111-16.
• van Geel PP, Pinto YM, Voors AA et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000;35:717-21.[Abstract/Free Full Text]
• Stephens JW, Dhamrait SS, Cooper JA et al. The D allele of the ACE I/D common gene variant is associated with type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005;84:83-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 2, 101-108 (2009)
DOI: 10.1177/1470320309104877


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bozkurt, O. Articles by Klungel, O. H PubMed PubMed Citation Articles by Bozkurt, O. Articles by Klungel, O. H Social Bookmarking                         What's this?